Tomorrow, our Chief AI Officer Max Jaderberg will be at the Sana AI Summit, alongside Tuomas Sandholm, exploring the future of science and knowledge. Join the waitlist and register to receive recordings from the event: bit.ly/sana-ai-summit…

Later today, our President, Colin Murdoch, will be speaking at STAT #STATBreakthrough Summit. Join him at 9.50am PDT to hear more about our work applying AI breakthroughs like #AlphaFold to drug design.

Join our CTO Sergei Yakneen at #VivaTech in Paris, May 22nd, 2.40 - 3.15pm CEST as he explores the potential for groundbreaking advancements in healthcare enabled by AI. #AI #machinelearning #drugdiscovery

Our Chief Scientific Officer Miles Congreve is delivering the keynote address at Prix Galien Forum UK on May 30th : Can we use artificial intelligence to design new drugs? If you’re attending, join Miles and learn more about how we’re doing it at Iso. #AI #drugdiscovery

Our General Counsel Sarah Korman joins Hans Sauer, Ryan Abbott and Andrei Iancu at #BIO2024. The panel will explore state-of-the-law and policy on AI-generated inventions globally and discuss how biopharma can protect AI inventions and the future of AI-powered innovation.

Our Chief AI Officer Max Jaderberg joined the Sana AI Summit a few weeks ago and discussed how breakthrough AI models like AlphaFold 3 can help us to reimagine drug design. You can watch the full conversation here: bit.ly/45873Nm

In the first episode of our ‘In Conversation’ series, Research Scientist Megan Egbert and ML Engineer Jack Lynch 🧪☕️ discuss tackling biological problems at scale by employing machine learning for in silico drug design at Iso. Join our team: bit.ly/3wuRQbL #AI #drugdiscovery

#AlphaFold 3, a cutting-edge AI model released jointly with Google DeepMind, provides an atomic-level view of the structure and interactions of biomolecular systems, deepening our understanding and helping us reimagine rational drug design. Read more: go.nature.com/4bNNlsJ

Research Leader, @franca_klg joins a panel at #WorkPride on Empowering Women in STEM Fields, hosted by our partners myGwork - LGBTQ+ business community. Sign up here to listen online on June 19th at 2pm BST: bit.ly/3Vvit9y

We’ll be at ICML Conference 21-27 July - if you'll be there we’d love to chat to you about our rational drug design work and opportunities to join our team. Register here bit.ly/3VSq6qx to arrange a time. #ICML2024

Come and talk to us about current opportunities to join our interdisciplinary team at ICML Conference on 21-27 July. Share your details here: bit.ly/3VSq6qx #ICML2024

ML Research Scientists Peter Wirnsberger and Daniele Grattarola discuss impactful ML research in application to drug design. If you’re attending #ICML2024 meet the team to hear how these techniques are applied at IsoLabs. Register your interest here: bit.ly/3VSq6qx

We’re here at #ICML2024! Come and talk to us to learn more about our work and opportunities to join the team at Isomorphic Labs. Register your interest here: bit.ly/3VSq6qx

Get an insight into the future of drug design from Pascal, one of our Research Leaders in Drug Design and Medical Research. In his blog, Pascal shares his perspective on the enormous potential surrounding AI-powered drug discovery. Read more here: bit.ly/3ylXsXb

Take a look at our CTO Sergei Yakneen latest blog on how Isomorphic Labs is using Google Cloud to deploy AI as part of the new frontier of technology powering drug design. Read more here: bit.ly/3T4gVTA

Congratulations to the team at @googledeepmind on the release of #AlphaProteo, an AI system that could accelerate our understanding of biological processes. Our scientists at Isomorphic Labs are excited to explore this model in application to drug design.

Congratulations to our CEO Demis Hassabis for being awarded a Leader on the #TIME100 AI List 2024 Read more here: time.com/time100ai

Our Chief AI Officer @MaxJaderberg spoke with Forbes writer Sai Balasubramanian, M.D., J.D. about the significance of AlphaFold 3 in advancing rational drug design at Isomorphic Labs, read more here: bit.ly/4d4mlFb

Delighted for Catherine Tong to be recognised by MIT MIT Technology Review as one of its Innovators Under 35. Since joining Iso her pioneering work in advancing digital health and the development of AlphaFold 3 has been inspiring. Congratulations Catherine! bit.ly/4cZ7qvW

In the latest episode of AI Game Changers, our CTO Sergei Yakneen shares aspirations with EPFL_AI_Center for AI to improve our understanding of disease biology and drive innovation in drug design at Isomorphic Labs: